Q1 2025 Intuitive Surgical Inc Earnings Call Transcript
Key Points
- Intuitive Surgical Inc (ISRG) reported strong procedure growth of 17% in the first quarter, with notable strength in general surgery in the US and regional performance in India, Korea, and the UK.
- The company placed 367 da Vinci systems in the quarter, including 147 da Vinci 5 systems, indicating robust demand for their latest technology.
- Revenue grew by 19% year-over-year, driven by solid procedure growth and capital performance.
- The rollout of da Vinci 5 is progressing well, with 147 systems placed and over 32,000 procedures performed, showcasing successful adoption.
- Intuitive Surgical Inc (ISRG) increased its full-year 2025 procedure growth forecast to a range of 15% to 17%, reflecting confidence in continued strong performance.
- The company faces potential challenges from tariffs, with an expected impact of approximately 1.7% of revenue in 2025, which could increase costs.
- Capital placements outside the US showed mixed performance, with stresses in key markets like Germany, the UK, and Japan due to financial pressures and healthcare spending constraints.
- The trade environment, particularly US-China tariffs, poses risks to future capital sales and may impact the ability to win tenders in China.
- Operating expenses increased by 12% year-over-year, driven by higher headcount and facilities-related costs, which could pressure margins.
- The company is supply-constrained on force-sensing instruments, limiting the ability to meet demand for this technology.
Thank you for standing by, and welcome to the Intuitive Surgical, Inc.'s first quarter 2025 earnings release. (Operator Instructions) As a reminder, today's program is being recorded.
And now I'd like to introduce your host for today's program, Dan Connally, Head of Investor Relations at Intuitive Surgical. Please go ahead, sir.
Good afternoon and welcome to Intuitive first-quarter earnings conference call. With me today, we have Gary Guthart, our CEO; Dave Rosa, our President, Jamie Samath, our CFO.
Before we begin, I would like to inform you that comments made on today's call may be deemed to contain forward-looking statements. Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties. These risks and uncertainties are described in detail in our Securities and Exchange Commission filings, including our most recent Form 10-K filed on January 31, 2025 and Form 10-Q filed on October 18, 2024. Our SEC filings can be found through
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |


